UK markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.55-0.16 (-1.54%)
As of 03:51PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9999
Avg. Estimate-0.07-0.0200.39
Low estimate-0.1-0.06-0.150.17
High estimate-0.030.010.180.62
Year ago EPS-0.18-0.15-0.510
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101111
Avg. Estimate111.19M124.94M529M680.81M
Low estimate107M120.75M511M618.98M
High estimate114.8M129.46M548.49M798.27M
Year ago sales83.08M94.5M399.36M529M
Sales growth (year/est)33.80%32.20%32.50%28.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.15-0.12-0.08-0.06
Actual EPS-0.18-0.15-0.07-0.11
Difference-0.03-0.030.01-0.05
Surprise %-20.00%-25.00%12.50%-83.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.07-0.0200.39
7 days ago-0.07-0.0200.39
30 days ago-0.06-0.0200.4
60 days ago-0.0500.060.52
90 days ago-0.0500.060.52
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesFOLDIndustrySector(s)S&P 500
Current qtr.61.10%N/AN/AN/A
Next qtr.86.70%N/AN/AN/A
Current year100.00%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)-147.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A